Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Summary of Product Characteristics last updated on the eMC: 19/06/2009
SPC Flixonase Nasule Drops

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/06/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 6 - Instructions for use, handling and disposal
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   23-Mar-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



 Section 1 - Change of units from "milligrammes/millilitre" to "mg/ml"

Section 2 - Change of units from "milligrammes/millilitre" to "mg/ml" Correction of excipient reference

Section 4.7 - "Not applicable" changed to "Not relevant"

Section 4.8 - MedDRA classification and frequecies applied

Section 6.2 - "None reported" changed to "Not applicable"

Section 6.6 - "No special requirements" added

Section 10 - Date of revision updated

Updated on 30/03/2009 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 6 - Instructions for use, handling and disposal
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   23-Mar-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 1 - Change of units from "milligrammes/millilitre" to "mg/ml"


Section 2 - Change of units from "milligrammes/millilitre" to "mg/ml" Correction of excipient reference

 

Section 4.7 - "Not applicable" changed to "Not relevant"


Section 4.8 - MedDRA classification and frequecies applied


Section 6.2 - "None reported" changed to "Not applicable"


Section 6.6 - "No special requirements" added


Section 10 - Date of revision updated

Updated on 21/02/2005 and displayed until 30/03/2009
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.8 - Undesirable Effects
Updated on 12/02/2004 and displayed until 21/02/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/02/2004 and displayed until 12/02/2004
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 6.1 - List of Excipients
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instruction for Use/Handling
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 11/04/2002 and displayed until 09/02/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/08/2001 and displayed until 11/04/2002
Reasons for adding or updating:
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 21/11/2000 and displayed until 10/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 08/11/1999 and displayed until 21/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   fluticasone propionate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk